Monthwise SARS CoV-2 mutation statistics
| Position | Mutation | Clade |
|---|---|---|
| 35 | nsp16:T35A; | CL-3b;CL-3e; |
| 91 | nsp16:T91-; | CL-3b; |
| 93 | nsp16:T93A; | CL-3d; |
| 118 | nsp16:V118I; | CL-1a_3b; |
| 118 | nsp16:V118L; | CL-3b;CL-3d;CL-3e;CL-3f; |
| 139 | nsp16:V139-; | CL-3e; |
| 139 | nsp16:V139A; | CL-3e; |
| 139 | nsp16:V139F; | CL-3b;CL-3e; |
| 139 | nsp16:V139I; | CL-3b;CL-3e; |
| 139 | nsp16:V139T; | CL-3b; |
| 167 | nsp16:V167-; | CL-3e; |
| 194 | nsp16:V194I; | CL-3e; |
| 197 | nsp16:V197-; | CL-2; |
| 223 | nsp16:V223G; | CL-3f; |
| 223 | nsp16:V223I; | CL-3b; |
| 259 | nsp16:V259-; | CL-3d; |
| 259 | nsp16:V259A; | CL-3c; |
| 288 | nsp16:V288-; | CL-3f; |
| 288 | nsp16:V288I; | CL-3b; |
| 289 | nsp16:V289A; | CL-3e; |
| 289 | nsp16:V289F; | CL-3b;CL-3d; |
| 289 | nsp16:V289G; | CL-5; |
| 289 | nsp16:V289I; | CL-3f; |
| 294 | nsp16:V294-; | CL-3b;CL-3c;CL-3e;CL-3f; |
| 294 | nsp16:V294A; | CL-2;CL-3c; |
| 294 | nsp16:V294F; | CL-3b;CL-3e;CL-3f; |
| 294 | nsp16:V294I; | CL-3a;CL-3e; |
| 296 | nsp16:V296F; | CL-3b; |
| 296 | nsp16:V296L; | CL-3e; |
| 296 | nsp16:V296N; | CL-3e; |
| 61 | nsp16:V61I; | CL-1b; |
| 67 | nsp16:V67I; | CL-3e; |
| 78 | nsp16:V78G; | CL-3b;CL-3c;CL-3d;CL-3e;CL-5; |
| 84 | nsp16:V84-; | CL-3e; |
| 9 | nsp16:V9-; | CL-3e; |
| 96 | nsp16:V96A; | CL-3b; |
| 9 | nsp16:V9A; | CL-3f; |
| 9 | nsp16:V9L; | CL-3f; |
| 176 | nsp16:W176-; | CL-3b;CL-3d; |
| 189 | nsp16:W189-; | CL-3b;CL-3c;CL-3e; |
| 88 | nsp16:W88-; | CL-3b; |
| 88 | nsp16:W88C; | CL-3e; |
| 15 | nsp16:Y15-; | CL-3e; |
| 211 | nsp16:Y211H; | CL-3f; |
| 222 | nsp16:Y222C; | CL-1a_3b;CL-3b;CL-3e; |
| 222 | nsp16:Y222N; | CL-3d; |
| 63 | nsp16:Y63C; | CL-3d; |
| 117 | nsp1:A117-; | CL-3b; |
| 117 | nsp1:A117D; | CL-1a; |
| 117 | nsp1:A117S; | CL-1b;CL-3e;CL-3f; |
Page 220 of 409
Tutorial Link
For More Web Development Tutorials Visit: AllPHPTricks.com